← 返回前沿论文

脆江蓠多糖经鼻给药可激发抗 Lewis 肺癌的免疫应答

英文原题:Intranasal Administration of Codium fragile Polysaccharide Elicits Anti-Cancer Immunity against Lewis Lung Carcinoma.

查看英文原题

Intranasal Administration of Codium fragile Polysaccharide Elicits Anti-Cancer Immunity against Lewis Lung Carcinoma.

PubMed 2021/09/30(内容时间) Int J Mol Sci Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

天然多糖在调节动物免疫方面已显示出良好效果。本研究考察了经鼻给予刺松藻多糖(CFPs)对小鼠的免疫刺激作用。在C57BL/6小鼠中经鼻给予CFPs可诱导纵隔淋巴结(mLN)中巨噬细胞和树突状细胞(DCs)表面活化标志物表达上调,以及支气管肺泡灌洗液中白细胞介素-6(IL-6)、IL-12p70和肿瘤坏死因子-α的产生。

此外,经鼻给予CFP后,通过上调C-C基序趋化因子受体7的表达,mLN中常规树突状细胞(cDCs)数量增加,cDCs亚群也被激活。

另外,经鼻给予CFPs促进了mLN中自然杀伤(NK)细胞和T细胞的活化,这些细胞产生促炎细胞因子和细胞毒性介质。最后,每日给予CFPs抑制了Lewis肺癌细胞向肺部的浸润,而CFPs对肿瘤生长的预防作用需要NK细胞和CD8 T细胞。

此外,CFPs联合抗程序性细胞死亡配体1(PD-L1)抗体(Ab)改善了抗PD-L1 Ab对肺癌的治疗效果。因此,这些数据表明,经鼻给予CFP诱导了针对肺癌的黏膜免疫。

展开英文摘要原文

Natural polysaccharides have shown promising effects on the regulation of immunity in animals. In this study, we examined the immune stimulatory effect of intranasally administered Codium fragile polysaccharides (CFPs) in mice. Intranasal administration of CFPs in C57BL/6 mice induced the upregulation of surface activation marker expression in macrophages and dendritic cells (DCs) in the mediastinal lymph node (mLN) and the production of interleukin-6 (IL-6), IL-12p70, and tumor necrosis factor-α in bronchoalveolar lavage fluid.

Moreover, the number of conventional DCs (cDCs) was increased in the mLNs by the upregulation of C-C motif chemokine receptor 7 expression, and subsets of cDCs were also activated following the intranasal administration of CFP.

In addition, the intranasal administration of CFPs promoted the activation of natural killer (NK) and T cells in the mLNs, which produce pro-inflammatory cytokines and cytotoxic mediators.

Finally, daily administration of CFPs inhibited the infiltration of Lewis lung carcinoma cells into the lungs, and the preventive effect of CFPs on tumor growth required NK and CD8 T cells.

Furthermore, CFPs combined with anti-programmed cell death-ligand 1 (PD-L1) antibody (Ab) improved the therapeutic effect of anti-PD-L1 Ab against lung cancer.

Therefore, these data demonstrated that the intranasal administration of CFP induced mucosal immunity against lung cancer.

论文信息

作者
Wang Y、An EK、Kim SJ、You S、Jin JO
第一作者单位
Shanghai Key Laboratory of Stomatology, Department of Prosthodontics, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.China
通讯作者单位
Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea.South Korea
期刊
International journal of molecular sciences2021 Sep 30
原文标识
PubMed 34638944 · DOI 10.3390/ijms221910608